Workers face intense challenges as radiation remains lethal and tasks must be performed in short shifts.
Japanese drugmaker Daiichi Sankyo’s (TYO:4568) Datroway (datopotamab deruxtecan) has been launched in the company’s home country for the treatment of adults with hormone receptor (HR) positive, HER2 ...
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...
The damaged Unit 1 reactor, back, and the exhaust stack shared by the Unit 1 and 2 reactors are seen at the Fukushima Daiichi nuclear power plant, operated by Tokyo Electric Power Company Holdings ...
On March 11, 2025, we remember the profound loss and resilience of the people of Japan following the Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster. Fourteen years later ...